Alain U. Vetterli
Directeur Général chez A&M Corp.
Relations actives
| Nom | Sexe | Age | Sociétés liées | Collaboration |
|---|---|---|---|---|
| Garry Paul McCann | M | 63 |
Pulmo BioTech, Inc.
 Pulmo BioTech, Inc. Medical SpecialtiesHealth Technology Pulmo BioTech, Inc. engages in the development and marketing of medical technology and research. It offers molecular imaging compounds designed for the diagnosis of Pulmonary Embolism, Pulmonary Hypertension and other conditions afflicting the Pulmonary Circulation. The company was founded on July 20, 2006 and is headquartered in New York, NY. | 16 ans |
| Peter B. Hirshfield | M | 78 |
Pulmo BioTech, Inc.
Pulmo BioTech, Inc. Medical SpecialtiesHealth Technology Pulmo BioTech, Inc. engages in the development and marketing of medical technology and research. It offers molecular imaging compounds designed for the diagnosis of Pulmonary Embolism, Pulmonary Hypertension and other conditions afflicting the Pulmonary Circulation. The company was founded on July 20, 2006 and is headquartered in New York, NY. | 16 ans |
Graphique Relationnel
Relation dans plusieurs entreprises
Anciennes relations
| Nom | Sexe | Age | Sociétés liées | Collaboration |
|---|---|---|---|---|
| Michael Vardakis | M | 59 |
Pulmo BioTech, Inc.
Pulmo BioTech, Inc. Medical SpecialtiesHealth Technology Pulmo BioTech, Inc. engages in the development and marketing of medical technology and research. It offers molecular imaging compounds designed for the diagnosis of Pulmonary Embolism, Pulmonary Hypertension and other conditions afflicting the Pulmonary Circulation. The company was founded on July 20, 2006 and is headquartered in New York, NY. | 3 ans |
| Matthew C. Lords | M | 55 |
Pulmo BioTech, Inc.
Pulmo BioTech, Inc. Medical SpecialtiesHealth Technology Pulmo BioTech, Inc. engages in the development and marketing of medical technology and research. It offers molecular imaging compounds designed for the diagnosis of Pulmonary Embolism, Pulmonary Hypertension and other conditions afflicting the Pulmonary Circulation. The company was founded on July 20, 2006 and is headquartered in New York, NY. | 3 ans |
| Robert Lawrence Banner | M | 80 |
Pulmo BioTech, Inc.
Pulmo BioTech, Inc. Medical SpecialtiesHealth Technology Pulmo BioTech, Inc. engages in the development and marketing of medical technology and research. It offers molecular imaging compounds designed for the diagnosis of Pulmonary Embolism, Pulmonary Hypertension and other conditions afflicting the Pulmonary Circulation. The company was founded on July 20, 2006 and is headquartered in New York, NY. | 1 ans |
| Ian Ilsley | M | 75 |
Pulmo BioTech, Inc.
Pulmo BioTech, Inc. Medical SpecialtiesHealth Technology Pulmo BioTech, Inc. engages in the development and marketing of medical technology and research. It offers molecular imaging compounds designed for the diagnosis of Pulmonary Embolism, Pulmonary Hypertension and other conditions afflicting the Pulmonary Circulation. The company was founded on July 20, 2006 and is headquartered in New York, NY. | 4 ans |
Statistiques
| Pays | Relations | % du total |
|---|---|---|
| Etats-Unis | 6 | 100,00% |
Age des relations
Actives
Passées
Homme
Femme
Administrateurs
Exécutifs
Provenance des relations
- Bourse
- Insiders
- Alain U. Vetterli
- Réseau Personnel
